ARTICLE | Company News
Sanofi, Evotec enter multi-part collaboration
March 21, 2015 1:57 AM UTC
Evotec AG (Xetra:EVT) gained EUR 0.27 to EUR 3.99 on Friday after it entered a multifaceted collaboration with Sanofi (Euronext:SAN; NYSE:SNY), including a five-year oncology research deal.
The companies intend to develop preclinical cancer candidates together and combine their small molecule libraries, which will be available for screening by Evotec's partners. Sanofi and Evotec also plan to jointly scout for academic projects in France in an effort to bolster Evotec's pipeline. ...